Kiley Juergens Wealth Management, LLC Gilead Sciences, Inc. Transaction History

Kiley Juergens Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 15, 2019	SELL	$60.54 - $79.0 $65,746 - $85,794	-1,086 Closed	0 $0
Q3 2018 Oct 10, 2018	BUY	$71.28 - $78.92 $55,954 - $61,952	785 Added 260.8%	1,086 $83,000
Q2 2018 Jul 23, 2018	BUY	$64.88 - $75.68 $19,528 - $22,779	301 New	301 $21,000
Q1 2018 Apr 23, 2018	SELL	$72.84 - $88.8 $21,924 - $26,728	-301 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $21,416 - $25,139	301	301 $21,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Kiley Juergens Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kiley Juergens Wealth Management, LLC with notifications on news.